– HealthMyne appoints Rose Higgins as the company’s new CEO, replacing Arvind Subramanian.
HealthMyne, a provider of quantitative imaging decision support software solutions, announced the appointment of Ms. Rose Higgins as the company’s new Chief Executive Officer (CEO). Prior to joining HealthMyne, Higgins served as President for SCIO Health Analytics, an EXL Services company. Higgins has also served in previous executive roles at McKesson and RelayHealth.
“Rose was selected to be CEO after an extensive search and we are excited to work with her on the opportunities ahead,” stated John Kuelper of Ascension Ventures, a HealthMyne board member who directed the search. “This is a critical time for HealthMyne as the company scales its customer base and extends its platform to new use cases and new stakeholders. Rose’s broad experience in healthcare technology will serve the company well in this time of rapid growth and development.”
Higgins replaces Arvind Subramanian, who retired after leading HealthMyne through the critical processes of developing HealthMyne’s core technology into a suite of clinical products.
HealthMyne Background
The core of HealthMyne’s platform enables precise extraction of quantitative imaging data from medical imaging data which is used to improve and automate clinical workflows in cancer screening, multidisciplinary conferences, incidental findings management, and therapy response assessments. This quantitative information includes both conventional measurements as well as novel radiomic data that is capable of powering predictive algorithms and precision medicine initiatives.
“I’m excited to join HealthMyne at this pivotal time in the company’s growth,” Higgins explained. “I look forward to building on the company’s excellent foundation of talented and committed employees, marquis customer relationships and transformative solutions.”
